Stocksigma LogoStocksigma Logo

Windlas Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)

■ Revenue: 2,639 (+18.7% YoY | +6.4% QoQ) ■ EBITDA: 294 (+2.8% YoY | +10.1% QoQ) ■ EBITDA Margin (%): 11.1 (-171 bps YoY | +37 bps QoQ) ■ PAT: 181 (+1.4%

Windlas Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million)

Windlas Biotech Ltd · Outcome · 05 Nov 2026, 9:48 pm

Windlas Biotech Ltd - Financial Result for the Quarter ended 30th Sep'26 (Standalone, INR Million) ■ Revenue: 2,639 (+18.7% YoY | +6.4% QoQ) ■ EBITDA: 294 (+2.8% YoY | +10.1% QoQ) ■ EBITDA Margin (%): 11.1 (-171 bps YoY | +37 bps QoQ) ■ PAT: 181 (+1.4% YoY | +2.3% QoQ) ■ EPS (INR): 8.56 (+1.9% YoY | +2.9% QoQ)

Original exchange filing (PDF)

More announcements from Windlas Biotech Ltd

All Windlas Biotech Ltd announcements